Their analysis of tumor tissue from almost 2500 patients with pancreatic cancer revealed that those lacking mutations of the KRAS gene (KRAS WT) frequently harbored mutations of genes associated with various critical cellular functions. This evidence concerns the gene KRAS and pancreatic neoplasm.